Malaria treatment2018-08-22T10:09:02+00:00

Project Description

U.S. regulators have approved a simple, one-dose treatment to prevent relapses of Plasmodium vivax malaria. One dose of GlaxoSmithKline’s Krintafel (tafenoquine) prevented relapses in three-in-four patients.

Project Details

Categories:

Project URL:

Malaria treatment

Copyright:

Graphic News